New study aims to improve cervical cancer detection in HIV-Positive women

NCT ID NCT06002126

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares different HPV tests to find the best way to screen for cervical cancer in women living with HIV in Latin America. Over 1,000 participants will provide cervical, vaginal, and urine samples, plus undergo colposcopy and biopsies. The goal is to identify which test most accurately detects precancerous lesions, enabling same-day diagnosis and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Xpert HPV test
What this could lead to
If successful, this could identify the most accurate and practical HPV testing method to prevent cervical cancer in women with HIV.
What could go wrong
This is an observational diagnostic study, not a treatment trial. Results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institute of Public Health, Mexico

    Cuernavaca, Morelos, 62209, Mexico

  • University of São Paulo

    São Paulo, São Paulo, 05403-911, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.